Upgrade to SI Premium - Free Trial

Deciphera Pharmaceuticals (DCPH) Tops Q1 EPS by 10c

May 4, 2022 7:15 AM

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q1 EPS of ($0.80), $0.10 better than the analyst estimate of ($0.90). Revenue for the quarter came in at $29.2 million versus the consensus estimate of $26.43 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

Categories

Earnings

Next Articles